The neuropathological findings in a patient with antemortem diagnosis of olivopontocerebellar atrophy (OPCA) and reduced leucocytic glutamate dehydrogenase (GDH) activity included cerebellar cortical degeneration, most marked in the superior vermis, mild atrophy of the pons and the inferior olivary nucleus, marked reduction of anterior horn cells at all levels and gliosis in both lateral columns. GDH activities and their thermolability in "soluble" and "particulate" fractions in the cerebral cortex, cerebellar hemisphere and vermis were not significantly different from the values in two control brains. GDH mRNA in the patient's brain was not altered in size or amount.
Accepted 20 March 1990 Initial reports of an association between low glutamate dehydrogenase (GDH) activity in patients with olivopontocerebellar atrophy (OPCA)'-' have not been confirmed by more recent clinical studies." 12 Moreover, several patients with OPCA and low leucocyte GDH activity have been found at necropsy to have distinctive pathologies. Thus GDH deficiency could not be correlated with a specific morbid entity. The first necropsy study of a patient with GDH deficiency and OPCA showed typical findings of OPCA with diffuse lipofuscinosis.' A second patient had neuronal intranuclear hyaline inclusion disease. ' The results were expressed as a ratio of GDH mRNA to GAD mRNA.'8 9 Since GDH and GAD mRNAs are of similar size (3 7 kb), the amount of nonspecific degradation should be similar. GDH/GAD mRNA ratio in the control frontal cortex was taken as unity. Results The average leucocyte GDH activity in our patient was 0 61 (SD 0 08) units. The control values derived from 26 non-diseased donors was 1-24 (SD 0 34) units'2 and in a concurrent series of20 multiple system atrophy cases, 1 00 (SD 029) units. Low GDH in our patient was persistent and reproducible on assays performed on leucocyte preparations at different times; the patient's total and differential WBC count on those days remained normal.
GDH activity was expressed in iimol NADH oxidised/hr/mg protein assayed at 35°C and the results are shown as mean (SD). There were no differences between the patient and the two controls in the thermolability of GDH in "soluble" and "particulate" fractions in whole homogenates and cerebellar hemisphere, cerebellar vermis or frontal cortex preparations. These studies were done by incubating the fractions at 45°C in a buffer containing 50 mM sodium phosphate, pH 7 4, to mimic the conditions used by others."6 To study the effects of other salts on thermolability, "particulate" and "soluble" fractions were heat treated in two other buffer systems, 100 mM potassium phosphate and 50 mM tris chloride, both at pH 7 4. No differences were seen in any condition between the patient and the two controls.
GDH mRNA was not altered in size in the brain regions including areas showing little or no gliotic response in the patient nor was there any evidence that GDH mRNA was reduced in amount. On the contrary, the ratio of GDH mRNA to GAD mRNA was increased twofold in each region. Another predominantly neuronal mRNA, glutaminase mRNA, was reduced in the patient compared to mRNA for GDH.
Discussion
The initial clinical picture in this patient and the necropsy findings of superior vermis and the anterior lobe atrophy in the cerebellum resemble those described by Marie et 
